Trials in Boston, Massachusetts
Here are the top 10 medical studies for alzheimer's disease in Boston, Massachusetts
Popular Filters
Phase 3 Trials
Anti-amyloid agent
Remternetug for Alzheimer's Disease
Recruiting0 awardsPhase 2 & 3
Providence, Rhode Island
This trial aims to test a drug called remternetug for its effectiveness in treating asymptomatic Alzheimer's disease in individuals with AD-causing mutations. The study will look at how remternetug
Anti-amyloid agent
ALZ-801 for Early Alzheimer's Disease
Recruiting2 awardsPhase 3
Plymouth, Massachusetts
"This trial is looking at how safe and effective ALZ-801 is for people with Early Alzheimer's disease who have a specific genetic marker. Participants will receive treatment with ALZ-801 in an open
Monoclonal Antibodies
Donanemab for Early Alzheimer's Disease
Recruiting1 awardPhase 3
Watertown, Massachusetts
This trial is testing different doses of donanemab, a drug aimed at helping people with early Alzheimer's disease. Donanemab has shown rapid reduction of brain amyloid in early Alzheimer's disease. The study will look at how often and how severely participants experience a side effect involving brain swelling. Researchers also want to find out which patient characteristics might predict this side effect.
Trials With No Placebo
Behavioural Intervention
Transcranial Direct Current Stimulation for Dementia
Recruiting1 award3 criteria
Roslindale, Massachusetts
"This trial aims to investigate how a 6-month personalized brain stimulation program done at home can improve cognitive function, walking, and mobility in older adults at risk of cognitive and motor decline."
Behavioral Intervention
Mindfulness for Alzheimer's Disease
Recruiting1 award1 criteria
Boston, Massachusetts
This trial aims to see if mindfulness meditation can help improve memory, brain function, and daily life in older adults with and without cognitive impairment. Participants will either take part in a mindfulness class or be placed
Monoclonal Antibodies
Foralumab for Mild Cognitive Impairment
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial will test the safety and effectiveness of Foralumab, a human antibody, in reducing inflammation in the brain to improve the immune response. The study will focus on participants with mild cognitive impairment
Anti-amyloid agent
ALZ-801 for Early Alzheimer's Disease
Recruiting2 awardsPhase 3
Plymouth, Massachusetts
"This trial is looking at how safe and effective ALZ-801 is for people with Early Alzheimer's disease who have a specific genetic marker. Participants will receive treatment with ALZ-801 in an open
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.